Mark Sabag

Mark Sabag

Executive Vice President, International Markets CommercialatTeva Pharmaceutical Industries· In proxies 2021–2023

Pay in FY2023-5% from the year before

Mark Sabag was paid $3.7M in FY2023 (Dec), down 5%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Teva Pharmaceutical Industries proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Teva Pharmaceutical IndustriesPublic company · 5 yr
    • Executive Vice President, International Markets Commercial2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?